João Victor de Melo Gomes

PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients

C. Nicco, F. Batteux, S. Chouzenoux, 2023, Inflammopharmacology.